295 related articles for article (PubMed ID: 34488908)
1. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
3. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
5. Opposing forces fight over the same ground to regulate interferon signaling.
Blalock WL
Biochem J; 2021 May; 478(10):1853-1859. PubMed ID: 34003254
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
8. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Detection of RIG-1, MDA5, and IFIT-1 Expression Is a Convenient Tool for Evaluation of the Interferon-Mediated Response.
Lozhkov AA; Plotnikova MA; Egorova MA; Baranovskaya IL; Elpaeva EA; Klotchenko SA; Vasin AV
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298646
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of RIG-I-like receptors in SARS-CoV-2 infection.
Yang D; Geng T; Harrison AG; Wang P
bioRxiv; 2021 Feb; ():. PubMed ID: 33594370
[TBL] [Abstract][Full Text] [Related]
12. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
13. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
MacDuff DA; Baldridge MT; Qaqish AM; Nice TJ; Darbandi AD; Hartley VL; Peterson ST; Miner JJ; Iwai K; Virgin HW
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209176
[TBL] [Abstract][Full Text] [Related]
14. RNF123 has an E3 ligase-independent function in RIG-I-like receptor-mediated antiviral signaling.
Wang S; Yang YK; Chen T; Zhang H; Yang WW; Song SS; Zhai ZH; Chen DY
EMBO Rep; 2016 Aug; 17(8):1155-68. PubMed ID: 27312109
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya Virus nsP2 Impairs MDA5/RIG-I-Mediated Induction of NF-κB Promoter Activation: A Potential Target for Virus-Specific Therapeutics.
Bae S; Lee JY; Myoung J
J Microbiol Biotechnol; 2020 Dec; 30(12):1801-1809. PubMed ID: 33323678
[TBL] [Abstract][Full Text] [Related]
19. Avian infectious bronchitis virus disrupts the melanoma differentiation associated gene 5 (MDA5) signaling pathway by cleavage of the adaptor protein MAVS.
Yu L; Zhang X; Wu T; Su J; Wang Y; Wang Y; Ruan B; Niu X; Wu Y
BMC Vet Res; 2017 Nov; 13(1):332. PubMed ID: 29132350
[TBL] [Abstract][Full Text] [Related]
20. LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.
Sanchez David RY; Combredet C; Najburg V; Millot GA; Beauclair G; Schwikowski B; Léger T; Camadro JM; Jacob Y; Bellalou J; Jouvenet N; Tangy F; Komarova AV
Sci Signal; 2019 Oct; 12(601):. PubMed ID: 31575732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
